Literature DB >> 8950794

Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions.

D Candinas1, N Koyamada, T Miyatake, J Siegel, W W Hancock, F H Bach, S C Robson.   

Abstract

Endothelial cell ATP diphosphohydrolases or ATPDases degrade extracellular inflammatory mediators ATP and ADP, thus inhibiting the formation of platelet thrombi, but the modulation of these ecto-enzymes during vascular injury remains largely undetermined. Renal glomerular ATPDase levels were determined in the rat following ischemia-reperfusion or systemic complement activation, by direct biochemical methods and histochemistry. Ischemia followed by reperfusion times over 30 min were associated with loss of glomerular ATPDase activity. Cobra Venom Factor (CVF) inhibited ATPDase activity and potentiated the deleterious effects of reperfusion. Treatment with either soluble complement receptor type 1 (sCR1), an inhibitor of complement activation, or antioxidants prior to the ischemia-reperfusion was largely protective. Expression of rat glomerular ATPDase activity appears susceptible to the inflammatory injury associated with systemic complement activation and ischemia/reperfusion processes. Oxidative stress could, at least in part, result in the loss of ATPDase activity and thus thrombotic consequences of vascular injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950794

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.

Authors:  M Imai; K Takigami; O Guckelberger; K Enjyoji; R N Smith; Y Lin; E Csizmadia; J Sévigny; R D Rosenberg; F H Bach; S C Robson
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

Review 2.  Regulation of the T Cell Response by CD39.

Authors:  Maisa C Takenaka; Simon Robson; Francisco J Quintana
Journal:  Trends Immunol       Date:  2016-05-25       Impact factor: 16.687

3.  Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia.

Authors:  Xiaofeng Sun; Masato Imai; Martina Nowak-Machen; Olaf Guckelberger; Keiichi Enjyoji; Yan Wu; Zain Khalpey; Pascal Berberat; Jeeva Munasinghe; Simon Christopher Robson
Journal:  Purinergic Signal       Date:  2011-06-09       Impact factor: 3.765

4.  Carbon monoxide protects the kidney through the central circadian clock and CD39.

Authors:  Matheus Correa-Costa; David Gallo; Eva Csizmadia; Edward Gomperts; Judith-Lisa Lieberum; Carl J Hauser; Xingyue Ji; Binghe Wang; Niels Olsen Saraiva Câmara; Simon C Robson; Leo E Otterbein
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

5.  Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.

Authors:  Mohsen Ibrahim; Xingan Wang; Carlos A Puyo; Alessandro Montecalvo; Howard J Huang; Ramsey R Hachem; Claudio Andreetti; Cecilia Menna; Ridong Chen; Alexander S Krupnick; Daniel Kreisel; Erino A Rendina; Andrew E Gelman
Journal:  J Heart Lung Transplant       Date:  2014-10-02       Impact factor: 10.247

6.  Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities.

Authors:  Patricia C Marisco; Fabiano B Carvalho; Michelle M Rosa; Bruna A Girardi; Jessié M Gutierres; Jeandre A S Jaques; Ana P S Salla; Víctor C Pimentel; Maria Rosa C Schetinger; Daniela B R Leal; Carlos F Mello; Maribel A Rubin
Journal:  Neurochem Res       Date:  2013-05-16       Impact factor: 3.996

7.  Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.

Authors:  K Koziak; M Bojakowska; S C Robson; K Bojakowski; J Soin; E Csizmadia; P Religa; Z Gaciong; E Kaczmarek
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

8.  Ectonucleotidases in the kidney.

Authors:  David G Shirley; Renu M Vekaria; Jean Sévigny
Journal:  Purinergic Signal       Date:  2009-03-31       Impact factor: 3.765

9.  Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice.

Authors:  Amir Behdad; Xiaofeng Sun; Zain Khalpey; Keiichi Enjyoji; Marcia Wink; Yan Wu; Anny Usheva; Simon C Robson
Journal:  Purinergic Signal       Date:  2009-03-24       Impact factor: 3.765

10.  Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.

Authors:  Florian Bönner; Nadine Borg; Sandra Burghoff; Jürgen Schrader
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.